Kraler, Simon

Calcific aortic valve disease: from molecular and cellular mechanisms to medical therapy

Kraler, S., Blaser, M. C., Aikawa, E., Camici, G. G., & Lüscher, T. F. (2022) · European Heart Journal

Cardiac Valve Diseases and TreatmentsCardiac Imaging and Diagnostics

Cited by 281

Multi-Omics Approaches to Define Calcific Aortic Valve Disease Pathogenesis

Blaser, M. C., Kraler, S., Lüscher, T. F., & Aikawa, E. (2021) · Circulation Research

Cardiac Valve Diseases and TreatmentsAortic Disease and Treatment Approaches

Cited by 109

Network-guided multiomic mapping of aortic valve calcification

Blaser, M. C., Kraler, S., Lüscher, T. F., & Aikawa, E. (2023) · Arteriosclerosis, Thrombosis, and Vascular Biology

Cardiac Valve Diseases and TreatmentsBioinformatics and Genomic Networks

Cited by 16

Sirtuin-1 directly binds and deacetylates hepatic PCSK9 thereby promoting the inhibition of LDL receptor degradation

Velagapudi, S., Miranda, M. X., Adla, P., Kraler, S., Mohammed, S. A., Baki, S., Robert, J., Rohrer, L., Lee, H., Jang, H.-D., et al. (2025) · Cardiovascular Research

Sirtuins and Resveratrol in MedicineCholesterol and Lipid Metabolism

Cited by 4